Primary Biliary Cholangitis Trial, Recruiting (NCT07607353)

Primary Biliary Cholangitis Trial, Recruiting NCT07607353 Sponsor: King's College Hospital NHS Trust Condition: Primary Biliary Cholangitis

Printed from Voxsanity (voxsanity.com.au) — NCT07607353 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Primary Biliary Cholangitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Primary Sclerosing Cholangitis (PSC), a liver/bile duct condition, and have a severely narrowed bile duct (called a "high grade stricture")

Who may not be able to join:

You have had a stent placed or a balloon procedure to open a bile duct in the last 4 months
You currently have signs of a serious bile duct infection (called bacterial cholangitis)
Your dose or type of a medication called UDCA (ursodeoxycholic acid) has been changed in the last 4 weeks
You are not able to give your own consent to take part in the trial
You have advanced liver scarring (cirrhosis) with a severity score above a certain level (confirm with trial site)
Your liver disease is considered severe enough that your expected survival without a transplant is less than 2 years, based on a specific scoring system (confirm with trial site)
There is a suspicion that you may have a type of bile duct cancer (cholangiocarcinoma), based on scans or blood test results
You currently have any other type of cancer, apart from a common and treatable skin cancer called basal cell carcinoma
Your overall life expectancy is estimated to be less than 24 months
You are pregnant at the time of screening
You have HIV, or active or long-term hepatitis B or hepatitis C infection, or have had problems with drug or alcohol misuse in the last 2 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07607353

Sponsor: King's College Hospital NHS Trust

Phase: Not Applicable

Status: Recruiting

Condition: Primary Biliary Cholangitis

More information: https://clinicaltrials.gov/study/NCT07607353

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Primary Sclerosing Cholangitis (PSC), a liver/bile duct condition, and have a severely narrowed bile duct (called a "high grade stricture")

Who may not be able to join:

You have had a stent placed or a balloon procedure to open a bile duct in the last 4 months
You currently have signs of a serious bile duct infection (called bacterial cholangitis)
Your dose or type of a medication called UDCA (ursodeoxycholic acid) has been changed in the last 4 weeks
You are not able to give your own consent to take part in the trial
You have advanced liver scarring (cirrhosis) with a severity score above a certain level (confirm with trial site)
Your liver disease is considered severe enough that your expected survival without a transplant is less than 2 years, based on a specific scoring system (confirm with trial site)
There is a suspicion that you may have a type of bile duct cancer (cholangiocarcinoma), based on scans or blood test results
You currently have any other type of cancer, apart from a common and treatable skin cancer called basal cell carcinoma
Your overall life expectancy is estimated to be less than 24 months
You are pregnant at the time of screening
You have HIV, or active or long-term hepatitis B or hepatitis C infection, or have had problems with drug or alcohol misuse in the last 2 years

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

King's College Hospital NHS Trust

Registry

ClinicalTrials.gov

Start date

1 March 2026

Est. completion

1 April 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Deployment of biodegradable stent placement across stricture at ERC in 20 patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov